HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: Compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates

Immunology Letters

Volumn 66, Issue 1-3, 1999, Pages 189-195

  Heeney, Jonathan ^a   Åkerblom, Lennart ^b   Barnett, Susan ^c   Bogers, Willy ^a   Davis, David ^d   Fuller, Deborah ^e   Koopman, Gerrit ^a   Lehner, Thomas ^f   Mooij, Petra ^a   Morein, Bror ^b   De Giuli Morghen, Carlo ^g   Rosenwirth, Brigitte ^a   Verschoor, Ernst ^a   Wagner, Ralf ^h   Wolf, Hans ^h  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c NOVARTIS PHARMA AG   (Switzerland)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e Powderject Vaccines   (United States)

^f GUY S HOSPITAL   (United Kingdom)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Correlation; HIV 1; Immune responses; Immunity; Pre clinical; Vaccine

Indexed keywords

BETA CHEMOKINE; DNA VACCINE; GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL MODEL; ANTIBODY RESPONSE; CONFERENCE PAPER; EXPERIMENTAL MODEL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; VACCINATION; VIRUS INFECTION;

AIDS VACCINES; ANIMALS; ANTIBODY FORMATION; CHEMOKINES, CC; CLINICAL TRIALS; HIV ANTIBODIES; HIV-1; HUMANS; IMMUNITY, CELLULAR; MACACA MULATTA; NEUTRALIZATION TESTS; REASSORTANT VIRUSES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0033019064     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(98)00157-6     Document Type: Conference Paper

References (40)

1. Editorial. Nat. Med. 4 (1998) 867-868.
2. Heeney J.L., Bruck C., Goudsmit J., Montagnier L., Schultz A., Tyrrell D., Zolla-Pazner S. Immunol. Today. 18:1997;4-8.
3. N.M. Almond, J.L. Heeney, AIDS 12 (1998) S133-140.
4. P.N. Fultz, Clin. Infect. Dis. 17 (Suppl. 1) (1993) S230-235.
5. J.L. Heeney, AIDS 10 (1996) S115-122.
6. Sakuragi S., Shibata R., Mukai R. et al. J. Gen. Virol. 73:1992;2983-2987.
7. Bogers W.M., Dubbes R., ten Haaft P. et al. Virology. 236:1997;110-117.
8. Reimann K.A., Li J.T., Veazey R., Halloran M., Park I.W., Karlsson G.B., Sodroski J., Letvin N.L. J. Virol. 70:1996;6922-6928.
9. Joag S.V., Li Z., Wang C., Jia F., Foresman L., Adany I., Pinson D.M., Stephens E.B., Narayan O. J. Med. Primatol. 27:1998;59-64.
10. Wagner R., Teeuwsen V.J., Deml L. et al. Virology. 245:1998;65-74.
11. Wagner R., Deml L., Schirmbeck R., Niedrig M., Reimann J., Wolf H. Virology. 220:1996;128-140.
12. P. Mooij, M. Van Der Kolk, W.M. Bogers, P.J. ten Haaft, P. Van Der Meide, N. Almond, J. Stott, M. Deschamps, D. Labbe, P. Momin, G. Voss, P. Von Hoegen, C. Bruck, J.L. Heeney, AIDS 12 (1998) F15-22.
13. E.J. Verschoor, P. Mooij, H. Oostermeijer, M. van der Kolk, P. ten Haaft, B. Verstrepen, B. Morein, L. Akerblom, D.H. Fuller, S.W. Barnett, J.L. Heeney, J. Virol. (1998) submitted.
14. Radaelli A., Gimelli M., Cremonesi C., Scarpini C., De Ginli Morghen C. Vaccine. 12:1994;1110-1117.
15. Radaelli A., De Ginli Morghen C. Vaccine. 12:1994;1101-1109.
16. Morein B., Lovgren K., Ronnberg B., Sjolander A., Villacres-Eriksson M. Clin. Immunother. 3:1995;461-475.
17. Morein B., Sundquist B., Hoglund S., Dalsgaard K., Osterhaus A. Nature. 308:1984;457-460.
18. Davis D., Morein B., Akerblom L., Lovgren-Bengtsson K., van Gils M.E., Bogers W.M., Teenwsen V.J., Heeney J.L. Vaccine. 15:1997;1661-1669.
19. Heeney J.L., van Gils M., Teenwsen V.J.P. et al. Proc. Natl. Acad. Sci. USA. 95:1998;10803-10808.
20. van der Meide P.H., Groenestein R.J., de Labie M.C.D.C., Heeney J.L., Pala P., Slaoui M. J. Med. Primatol. 24:1995;271-281.
21. Wang Y., Tao L., Mitchell E. et al. Proc. Natl. Acad. Sci. USA. 95:1998;5223-5228.
22. Lehner T., Wang Y., Cranage M. et al. Nat. Med. 2:1996;767-775.
23. Li J., Lord C.I., Haseltine W., Letvin N.L., Sodroski J. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 5:1992;639-646.
24. Cheng-Mayer C., Seto D., Tateno M., Levy J.A. Science. 240:1988;80-82.
25. Cheng-Mayer C., Shioda T., Levy J.A. J. Virol. 65:1991;6931-6941.
26. P.J.F. ten Haaft, B. Verstrepen, K. Uberla, B. Rosenwirth, J.L. Heeney, J. Virol. (1998) in press.
27. J.L. Heeney, M.E. van Gils, P. van der Meide, C. de Ginli Morghen, C. Ghioni, M. Gimelli, A. Raddelli, D. Davis, L. Akerblom, B. Morein, J. Med. Primatol. (1998) 50-58.
28. Dragic T., Litwin V., Allaway G.P. et al. Nature. 381:1996;667-673.
29. Deng H., Liu R., Ellmeier W. et al. Nature. 381:1996;661-666.
30. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. Science. 272:1996;1955-1958.
31. Choe H., Farzan M., Sun Y. et al. Cell. 85:1996;1135-1148.
32. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S.C., Parmentier M., Collman R.G., Doms R.W. Cell. 85:1996;1149-1158.
33. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo RC., Lusso P. Science. 270:1995;1811-1815.
34. Paxton W.A., Martin S.R., Tse D. et al. Nat. Med. 2:1996;412-417.
35. Murthy K.K., Cobb E.K., Rouse S.R., Lunceford S.M., Johnson D.E., Galvan A.R. Immunol. Lett. 51:1996;121-124.
36. Bruck C., Thiriart C., Fabry L. et al. Vaccine. 12:1994;1141-1148.
37. ten Haaft P.J.F., Cornelissen M., Goudsmit J. et al. J. Gen. Virol. 76:1995;1015-1020.
38. N.L. Haigwood, A. Watson, J. McClure, W.F. Sutton, J. Ranchalis, B. Travis, S.-H. Hu, V.M. Hirsch, G. Voss, N.L. Letvin, A. Lewis, P.R. Johnson, in: R.M. Chanock, F. Brown, H.S. Ginsberg E. Norrby (Eds.), Vaccines 95, vol. 1, Cold Spring Harbor Laboratory Press, New York, 1995 pp. 149-158.
39. Heeney J.L., van Els C., de Vries P. et al. J. Exp. Med. 180:1994;769-774.
40. Gallimore A., Cranage M., Cook N. et al. Nat. Med. 1:1995;1167-1173.